C-type natriuretic peptide/guanylate cyclase B system in rat osteogenic ROB-C26 cells and its down-regulation by dexamethazone

被引:28
作者
Suda, M [1 ]
Komatsu, Y [1 ]
Tanaka, K [1 ]
Yasoda, A [1 ]
Sakuma, Y [1 ]
Tamura, N [1 ]
Ogawa, Y [1 ]
Nakao, K [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan
关键词
C-type natriuretic peptide; guanylate cyclase-B; osteogenic cell; ROB-C26; dexamethasane;
D O I
10.1007/s002239900735
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is recent evidence that natriuretic peptides are important regulators of bone and cartilage, although they were originally identified as the cardiac hormones causing natriuresis and hypotension. Three members of natriuretic peptide family are known: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). The biologically active receptors for these peptides are particulate guanylate cyclases; the two known types are GC-A and GC-B. ANP and BNP have high affinities for GC-A, and CNP is the preferred Ligand for GC-B. In this paper we report the results of our study of the expression and possible role(s) of natriuretic peptides in the ROB-C26 cell, which is an osteogenic cell Line with multiple potentials for differentiating into myoblast, osteoblast, and adipocyte. ROB-C26 cells produced cGMP in response to natriuretic peptides at both their basal state and after enhanced differentiation into osteoblast which was induced by bone morphogenetic protein [(BMP)-2]. CNP was far more patent than ANP in cGMP production. In contrast, enhanced differentiation into adipocyte by dexamethasone resulted in the marked decrease in their responsiveness to natriuretic peptides. Although the messages for GC-A and GC-B were demonstrated by Northern blot analysis at both the basal stage and after BMP treatment, they were down-regulated after dexamethasone treatment. The presence of CNP was shown by RT-PCR and immunohistochemistry in ROB-C26 cells. C3H10T1/2, which is another and more primitive mesenchymal cell line, also produced cGMP in response to CNP, and less potently to ANP. Culturing-ROB-C26 cells with CNP or X-bromo cGMP decreased [H-3]thymidine uptake and slightly increased the message for alkaline phosphatase, which is a marker for osteoblast differentiation. These results suggest that the CNP/GC-B system is preferentially expressed in the cells of osteogenic lineage and their expression is down-regulated with differentiation into adipocyte lineage. The CNP/GC-B system is likely to be an autocrine/paracrine regulator of osteoblast growth and differentiation.
引用
收藏
页码:472 / 478
页数:7
相关论文
共 22 条
[1]   cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells [J].
Hagiwara, H ;
Inoue, A ;
Yamaguchi, A ;
Yokose, S ;
Furuya, M ;
Tanaka, S ;
Hirose, S .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (05) :C1311-C1318
[2]   C-TYPE NATRIURETIC PEPTIDE INCREASES BONE-RESORPTION IN 1,25-DIHYDROXYVITAMIN D-3 STIMULATED MOUSE BONE-MARROW CULTURES [J].
HOLLIDAY, LS ;
DEAN, AD ;
GREENWALD, JE ;
GLUCK, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :18983-18989
[3]   Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells [J].
Inoue, A ;
Hiruma, Y ;
Hirose, S ;
Yamaguchi, A ;
Furuya, M ;
Tanaka, S ;
Hagiwara, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (03) :703-707
[4]   RECIPROCAL REGULATION BY CYCLIC-NUCLEOTIDES OF THE DIFFERENTIATION OF RAT OSTEOBLAST-LIKE CELLS AND MINERALIZATION OF NODULES [J].
INOUE, A ;
HIRUMA, Y ;
HIROSE, S ;
YAMAGUCHI, A ;
HAGIWARA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (03) :1104-1110
[5]   THE NONOSTEOGENIC MOUSE PLURIPOTENT CELL-LINE, C3H10T1/2, IS INDUCED TO DIFFERENTIATE INTO OSTEOBLASTIC CELLS BY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 [J].
KATAGIRI, T ;
YAMAGUCHI, A ;
IKEDA, T ;
YOSHIKI, S ;
WOZNEY, JM ;
ROSEN, V ;
WANG, EA ;
TANAKA, H ;
OMURA, S ;
SUDA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (01) :295-299
[6]   C-TYPE NATRIURETIC PEPTIDE (CNP) IN RATS AND HUMANS [J].
KOMATSU, Y ;
NAKAO, K ;
SUGA, S ;
OGAWA, Y ;
MUKOYAMA, M ;
ARAI, H ;
SHIRAKAMI, G ;
HOSODA, K ;
NAKAGAWA, O ;
HAMA, N ;
KISHIMOTO, I ;
IMURA, H .
ENDOCRINOLOGY, 1991, 129 (02) :1104-1106
[7]   Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein [J].
Luo, GB ;
Ducy, P ;
McKee, MD ;
Pinero, GJ ;
Loyer, E ;
Behringer, RR ;
Karsenty, G .
NATURE, 1997, 386 (6620) :78-81
[8]  
Marks Sandy C. Jr., 1996, P3
[9]   DISTRIBUTION OF C-TYPE NATRIURETIC PEPTIDE AND ITS MESSENGER-RNA IN RAT CENTRAL-NERVOUS-SYSTEM AND PERIPHERAL TISSUE [J].
MINAMINO, N ;
ABURAYA, M ;
KOJIMA, M ;
MIYAMOTO, K ;
KANGAWA, K ;
MATSUO, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (01) :326-335
[10]   BRAIN NATRIURETIC PEPTIDE AS A NOVEL CARDIAC HORMONE IN HUMANS - EVIDENCE FOR AN EXQUISITE DUAL NATRIURETIC PEPTIDE SYSTEM, ATRIAL-NATRIURETIC-PEPTIDE AND BRAIN NATRIURETIC PEPTIDE [J].
MUKOYAMA, M ;
NAKAO, K ;
HOSODA, K ;
SUGA, S ;
SAITO, Y ;
OGAWA, Y ;
SHIRAKAMI, G ;
JOUGASAKI, M ;
OBATA, K ;
YASUE, H ;
KAMBAYASHI, Y ;
INOUYE, K ;
IMURA, H .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1402-1412